Hourly refreshFri, Jul 24, 2026

Press Release Database

Recent press releases, indexed by topic.
AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
Results
Showing all · 42258 itemsDownloadExcelTXT
In the wire

UAB Urbo bankas repurchased part of its own shares

UAB Urbo bankas (hereinafter – the Bank), juridinio asmens kodas 112027077, adresas: Konstitucijos pr. 18B, Vilnius.

Jul 24 · 06:00GlobeNewswire
In the wire

UAB Urbo bankas supirko dalį savo akcijų

UAB Urbo bankas (toliau – Bankas), juridinio asmens kodas 112027077, adresas: Konstitucijos pr. 18B, Vilnius.

Jul 24 · 06:00GlobeNewswire
Finance

Loomis Interim Report January - June 2026

STOCKHOLM, July 24, 2026 /PRNewswire/ -- Continued strong growth and record operating margin (EBITA %) President and CEO Aritz Larrea comments: "We delivered another very strong quarter reflecting the continued execution of our strategy and the strength of our diversified model. Revenue...

Jul 24 · 05:55PR Newswire
In the wire

Tigera lance Calico basé sur eBPF pour les machines virtuelles sur Kubernetes : migration de machines virtuelles ne nécessitant pas de reconfiguration du réseau

Les entreprises ayant décidé de migrer leurs machines virtuelles depuis VMware ont besoin d'une alternative à NSX pour l'automatisation du réseau et la simplification des opérations liées aux machines virtuelles et aux conteneurs fonctionnant sur Kubernetes SAN JOSE, Californie, 24...

Jul 24 · 05:53PR Newswire
In the wire

В Шаньси проходит диалог о глобальном наследии

ЦЗИНЬЧЖУН, Китай, 24 июля 2026 г. /PRNewswire/ -- Новостной репортаж China Daily: Международная неделя охраны культурного наследия 2026 (2026 International Cultural Heritage Protection Week), посвященная теме «Единство во имя процветания, наследие ради вечности», завершилась во вторник в...

Jul 24 · 05:52PR Newswire
In the wire

Communiqué de presse: Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales

Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales

Jul 24 · 05:30GlobeNewswire
In the wire

Inbank appoints new Chief Technology Officer and changes Management Board composition

Following the announcement of changes to Inbank's operating model on 19 June 2026, the Inbank Supervisory Board has resolved to appoint Marten Meikop as Chief Technology Officer (CTO) and member of the Management Board, effective 10 August 2026.

Jul 24 · 05:30GlobeNewswire
In the wire

Inbank nimetab ametisse uue tehnoloogiajuhi ning muudab juhatuse koosseisu

Jätkuna 19. juunil 2026 avaldatud teatele Inbanki tegevusmudeli muudatustest on Inbanki nõukogu otsustanud nimetada Marten Meikopi Inbanki tehnoloogiajuhiks ( Chief Technology Officer, CTO ) ja juhatuse liikmeks alates 10. augustist 2026. Ühtlasi otsustas nõukogu pikendada Inbanki riskijuhi Evelin Lindversi ametiaega kolme aasta võrra alates 7. augustist 2026 ning kutsuda Ivar Kurvits juhatusest tagasi alates 31. juulist 2026. Ivar jätkab Corporate Development & Strategy üksuse juhina. Kommenteerib juhatuse esimees ja tegevjuht Priit Põldoja: „Mul on hea meel, et Inbankiga liitub Marten, kellel on pikaajaline kogemus piiriüleste tehnoloogiaplatvormide ülesehitamisel ja suurte inseneriorganisatsioonide juhtimisel kiire kasvu perioodidel. Üks Marteni peamisi prioriteete saab olema meie t

Jul 24 · 05:30GlobeNewswire
Healthcare

Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews

Sanofi today announced discontinuation of clinical development of amlitelimab, an OX40-ligand monoclonal antibody, in moderate-to-severe atopic dermatitis.

Jul 24 · 05:30GlobeNewswire
In the wire

Vitura: First-half 2026 Results

PARIS, July 24, 2026--Regulatory News: Vitura (Paris:VTR):

Jul 24 · 05:30mlpr-businesswire
Finance

Shareholder Alert: Ademi LLP investigates whether Safety Insurance Group, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, July 24, 2026 /PRNewswire/ -- Ademi LLP is investigating Safety (NASDAQ: SAFT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Mapfre. Click here to learn how to join our investigation and obtain additional...

Jul 24 · 05:27PR Newswire
In the wire

As U.S. Social Commerce Crosses $100 Billion, YFCon 2026 Brings Brands and TikTok Shop Creators Together in Anaheim Ahead of the Holidays

Jul 24 · 05:20GetNews
← Prev1233522Next →